XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Feb. 05, 2023   304,076      
Beginning balance at Feb. 05, 2023 $ 941,233 $ 30 $ 2,493,769 $ (15,504) $ (1,537,062)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   3,400      
Issuance of common stock upon exercise of stock options 29,882   29,882    
Stock-based compensation expense 169,677   169,677    
Vesting of restricted stock units (in shares)   7,175      
Vesting of restricted stock units 0 $ 1 (1)    
Tax withholding on vesting of restricted stock units (in shares)   (415)      
Tax withholding on vesting of restricted stock units (11,827)   (11,827)    
Common stock issued under employee stock purchase plan (in shares)   1,069      
Common stock issued under employee stock purchase plan 21,219   21,219    
Repurchase of common stock (in shares)   (3,467)      
Repurchases of common stock (91,881)   (91,881)    
Issuance of common stock upon conversion of convertible senior notes (in shares)   1      
Issuance of common stock upon conversion of convertible senior notes (356)   (356)    
Other comprehensive income (loss) 2,897     2,897  
Net income (loss) (74,516)       (74,516)
Ending balance (in shares) at Aug. 06, 2023   311,839      
Ending balance at Aug. 06, 2023 986,328 $ 31 2,610,482 (12,607) (1,611,578)
Beginning balance (in shares) at May. 07, 2023   306,453      
Beginning balance at May. 07, 2023 905,807 $ 31 2,521,145 (10,906) (1,604,463)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   2,610      
Issuance of common stock upon exercise of stock options 25,263   25,263    
Stock-based compensation expense 91,012   91,012    
Vesting of restricted stock units (in shares)   3,505      
Vesting of restricted stock units 0        
Tax withholding on vesting of restricted stock units (in shares)   (134)      
Tax withholding on vesting of restricted stock units (5,068)   (5,068)    
Repurchase of common stock (in shares)   (595)      
Repurchases of common stock (21,970)   (21,970)    
Issuance of common stock upon conversion of convertible senior notes 100   100    
Other comprehensive income (loss) (1,701)     (1,701)  
Net income (loss) (7,115)       (7,115)
Ending balance (in shares) at Aug. 06, 2023   311,839      
Ending balance at Aug. 06, 2023 986,328 $ 31 2,610,482 (12,607) (1,611,578)
Beginning balance (in shares) at Feb. 04, 2024   319,523      
Beginning balance at Feb. 04, 2024 1,270,094 $ 32 2,749,595 (3,782) (1,475,751)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   1,407      
Issuance of common stock upon exercise of stock options 17,768   17,768    
Stock-based compensation expense 221,478   221,478    
Vesting of restricted stock units (in shares)   6,705      
Vesting of restricted stock units $ 0 $ 1 (1)    
Tax withholding on vesting of restricted stock units (in shares) (1,400) (1,365)      
Tax withholding on vesting of restricted stock units $ (88,661)   (88,661)    
Common stock issued under employee stock purchase plan (in shares)   1,195      
Common stock issued under employee stock purchase plan 25,328   25,328    
Other comprehensive income (loss) 6,489     6,489  
Net income (loss) 665       665
Ending balance (in shares) at Aug. 04, 2024   327,465      
Ending balance at Aug. 04, 2024 1,453,161 $ 33 2,925,507 2,707 (1,475,086)
Beginning balance (in shares) at May. 05, 2024   325,181      
Beginning balance at May. 05, 2024 1,373,973 $ 33 2,890,284 (5,584) (1,510,760)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   373      
Issuance of common stock upon exercise of stock options 4,545   4,545    
Stock-based compensation expense 106,861   106,861    
Vesting of restricted stock units (in shares)   3,026      
Vesting of restricted stock units $ 0        
Tax withholding on vesting of restricted stock units (in shares) (1,100) (1,115)      
Tax withholding on vesting of restricted stock units $ (76,183)   (76,183)    
Other comprehensive income (loss) 8,291     8,291  
Net income (loss) 35,674       35,674
Ending balance (in shares) at Aug. 04, 2024   327,465      
Ending balance at Aug. 04, 2024 $ 1,453,161 $ 33 $ 2,925,507 $ 2,707 $ (1,475,086)